InvestorsHub Logo
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: CogDiss 1188X post# 208121

Saturday, 01/12/2019 3:36:51 PM

Saturday, January 12, 2019 3:36:51 PM

Post# of 721171
And Cog, this is not a bad overview of all the current immunotherapy research approaches for GBM, and goes into the biology of all the different approaches. And DCVax gets a deserved positive mention.

There appear to be no current competitors at an advanced P3 stage.


https://nnjournal.net/article/view/2902#B89
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News